CVD Prevention Perspective

 
 

  • Feb 3 2023 This Week in Cardiology   A possible major breakthrough in thinking about diastolic dysfunction and HFpEF, MRI scanning and cardiac devices, and AF and dementia are the topics John Mandrola, MD, covers in this week’s podcast.
  • The New Blood Pressure Target in Primary Care   Dr Neil Skolnik discusses the rationale for the new lower blood pressure target for adults with hypertension.
  • S2 Episode 2: Recognizing the Signs: Heart Failure and Type 2 Diabetes   Join Dr Carol Wysham and Dr Javed Butler as they discuss the stealth complication of heart failure in patients with type 2 diabetes, including subtle signs and symptoms of heart failure and the importance of early detection and treatment.
  • S2 Episode 1: How to Care for Older Adults With Type 2 Diabetes   Drs Carol Wysham and Medha N. Munshi discuss the unique challenges and strategies when treating older adults with type 2 diabetes.
  • Universal Testing for Lp(a): What Are We Waiting For? A retired cardiologist with a personal history with the atherogenic molecule calls for universal testing for lipoprotein (a).
  • Change Makers: Dr Rice on Disparities and Moving From Talk to Action WebMD's Chief Medical Officer, John Whyte, MD, MPH, speaks with Valerie Montgomery Rice, MD, on cultural humility in healthcare disparities.
  • Does Evidence Support Pharmacologic Treatment for Dementia? Although patients and their family members long for effective treatments for dementia, high-quality evidence on the benefits of the drugs already available is lacking.
  • Jan 27 2023 This Week in Cardiology   Exercise for AF, drugs have more than one effect, AI bots and the future of medicine, and the good and bad news about prognosis in HF are the topics John Mandrola, MD, discusses in this week's podcast.
  • Jan 20 2023 This Week in Cardiology   The loop diuretic duels, adverse events during hospital admissions, BP accuracy, and left main revascularization strategies (again) are the topics John Mandrola discusses in this week’s podcast.
  • Cardiorespiratory Fitness Early-Post Breast Cancer Therapy This review explores the use of multi-modal exercise-based rehabilitation programs to help improve cardiovascular outcomes and reduce CVD risk in survivors of breast cancers.
  • Jan 13 2023 This Week in Cardiology   FOURIER authors' response, a possible practice-changing paper in electrophysiology, and the ATLAS and CAPLA trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  • Atrial Fibrillation: Sex Differences and Modifiable Risk Factors   Who has more AF: men or women? Do vitamin D or omega-3s make a difference?
  • Jan 6 2023 This Week in Cardiology   Damar Hamlin, obesity and semaglutide, Open Data and PCSK9 inhibitors, and TAVI vs SAVR trials are the topics John Mandrola, MD, discusses in this week’s podcast.
  • What About Lp(a)? To Test or Not to Test   Drs Seth Baum and Matthew Budoff discuss the importance of and considerations for Lp(a) screening to optimize patient care.
  • Does Vitamin D Deficiency Cause Obesity or Vice Versa? Vitamin D deficiency has been cited as a possible cause of obesity. Dr Caroline Apovian talks about vitamin D and whether it has a role in obesity development.
  • Dec 23 2022 This Week in Cardiology   The top ten stories of the year plus a few honorary mentions.
  • To Stop COVID, We Must Clean Up Our Air   Two-way masking is pretty effective, but it's not sustainable. Environmental engineer and viral transmission expert Dr Linsey Marr reveals how we can fight COVID by tackling our contaminated air.
  • 'Making Targets Easier to Achieve' Key in Diabetes Care   Anne L. Peters, MD, discusses how the new updates to the American Diabetes Association 2023 Standards of Care in Diabetes can help clinicians improve patient care.
  • Top Cardiology Trials of 2022   Trials on heart failure, hypertension and lipid-lowering drugs, and the evolution of antithrombin and antiplatelet therapy are discussed in part 2 of cardiologists Bob Harrington and Mike Gibson's annual review.
  • 2022 in Review Through a Cardiology Lens   In part 1 of their annual review, cardiologists Bob Harrington and Mike Gibson discuss in-person meetings, wearables and AI, COVID lessons for medical research, and the growth of RCTs from China.